Our research revealed that low NFKBIZ level indicated a poor prognosis for HCC patients and NFKBIZ modulated the proliferation and metastasis of HCC cells via regulating NFκB pathway. The gene discussed is NFKBIZ; the disease is hepatocellular carcinoma.